U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Macular hyperpigmentation

MedGen UID:
488933
Concept ID:
C0745109
Finding; Finding
HPO: HP:0011509

Definition

Increased amount of pigmentation in the macula lutea. [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVMacular hyperpigmentation

Conditions with this feature

Renal coloboma syndrome
MedGen UID:
339002
Concept ID:
C1852759
Disease or Syndrome
PAX2-related disorder is an autosomal dominant disorder associated with renal and eye abnormalities. The disorder was originally referred to as renal coloboma syndrome and characterized by renal hypodysplasia and abnormalities of the optic nerve; with improved access to molecular testing, a wider range of phenotypes has been recognized in association with pathogenic variants in PAX2. Abnormal renal structure or function is noted in 92% of affected individuals and ophthalmologic abnormalities in 77% of affected individuals. Renal abnormalities can be clinically silent in rare individuals. In most individuals, clinically significant renal insufficiency / renal failure is reported. End-stage renal disease requiring renal transplant is not uncommon. Uric acid nephrolithiasis has been reported. Ophthalmologic abnormalities are typically described as optic nerve coloboma or dysplasia. Iris colobomas have not been reported in any individual with PAX2–related disorder. Ophthalmologic abnormalities may significantly impair vision in some individuals, while others have subtle changes only noted after detailed ophthalmologic examination. Additional clinical findings include high-frequency sensorineural hearing loss, soft skin, and ligamentous laxity. PAX2 pathogenic variants have been identified in multiple sporadic and familial cases of nonsyndromic renal disease including renal hypodysplasia and focal segmental glomerulosclerosis.
Cone-rod dystrophy 2
MedGen UID:
483485
Concept ID:
C3489532
Disease or Syndrome
Cone-rod dystrophy (CORD) characteristically leads to early impairment of vision. An initial loss of color vision and of visual acuity is followed by nyctalopia (night blindness) and loss of peripheral visual fields. In extreme cases, these progressive symptoms are accompanied by widespread, advancing retinal pigmentation and chorioretinal atrophy of the central and peripheral retina (Moore, 1992). In many families, perhaps a majority, central and peripheral chorioretinal atrophy is not found (Tzekov, 1998). Genetic Heterogeneity of Autosomal Cone-Rod Dystrophy There are several other autosomal forms of CORD for which the molecular basis is known. CORD3 (604116) is caused by mutation in the ABCA4 gene (601691) on chromosome 1p22. CORD5 (600977) is caused by mutation in the PITPNM3 gene (608921) on chromosome 17p13. CORD6 (601777) is caused by mutation in the GUCY2D gene (600179) on chromosome 17p13.1. CORD9 (612775) is caused by mutation in the ADAM9 gene (602713) on chromosome 8p11. CORD10 (610283) is caused by mutation in the SEMA4A gene (607292) on chromosome 1q22. CORD11 (610381) is caused by mutation in the RAXL1 gene (610362) on chromosome 19p13. CORD12 (612657) is caused by mutation in the PROM1 gene (604365) on chromosome 4p15. CORD13 (608194) is caused by mutation in the RPGRIP1 gene (605446) on chromosome 14q11. CORD14 (see 602093) is caused by mutation in the GUCA1A gene (600364) on chromosome 6p21. CORD15 (613660) is caused by mutation in the CDHR1 gene (609502) on chromosome 10q23. CORD16 (614500) is caused by mutation in the C8ORF37 gene (614477) on chromosome 8q22. CORD18 (615374) is caused by mutation in the RAB28 gene (612994) on chromosome 4p15. CORD19 (615860) is caused by mutation in the TTLL5 gene (612268) on chromosome 14q24. CORD20 (615973) is caused by mutation in the POC1B gene (614784) on chromosome 12q21. CORD21 (616502) is caused by mutation in the DRAM2 gene (613360) on chromosome 1p13. CORD22 (619531) is caused by mutation in the TLCD3B gene (615175) on chromosome 16p11. CORD23 (see 613428) is caused by mutation in the C2ORF71 gene (PCARE; 613425) on chromosome 2p23. CORD24 (620342) is caused by mutation in the UNC119 gene (604011) on chromosome 17q11. A diagnosis of CORD was made in an individual with a mutation in the AIPL1 gene (604392.0004) on chromosome 17p13.1, as well as in an individual with a mutation in the UNC119 gene (604011.0001) on chromosome 17q11.2. Other mapped loci for autosomal CORD include CORD1 (600624) on chromosome 18q21.1-q21.3; CORD7 (603649) on chromosome 6q14; CORD8 (605549) on chromosome 1q12-q24; and CORD17 (615163) on chromosome 10q26. For a discussion of X-linked forms of cone-rod dystrophy, see CORDX1 (304020).

Professional guidelines

PubMed

Taylor S, Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, Gonzalez N, Weiss J, Kang S, Desai SR
J Am Acad Dermatol 2023 Aug;89(2):316-323. Epub 2023 Mar 15 doi: 10.1016/j.jaad.2023.02.053. PMID: 36924935
Bishnoi A, Vinay K, Parsad D, Kumar S, Chatterjee D, Nahar Saikia U, Sendhil Kumaran M
Australas J Dermatol 2021 Aug;62(3):278-285. Epub 2021 Mar 4 doi: 10.1111/ajd.13567. PMID: 33660856
Kumarasinghe SPW, Pandya A, Chandran V, Rodrigues M, Dlova NC, Kang HY, Ramam M, Dayrit JF, Goh BK, Parsad D
Int J Dermatol 2019 Mar;58(3):263-272. Epub 2018 Sep 3 doi: 10.1111/ijd.14189. PMID: 30176055

Recent clinical studies

Etiology

Taylor S, Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, Gonzalez N, Weiss J, Kang S, Desai SR
J Am Acad Dermatol 2023 Aug;89(2):316-323. Epub 2023 Mar 15 doi: 10.1016/j.jaad.2023.02.053. PMID: 36924935
Sarkar R, Vinay K, Bishnoi A, Poojary S, Gupta M, Kumaran MS, Jain A, Gurumurthy C, Arora P, Kandhari R, Rathi S, Zawar V, Gupta V, Ravivarma VN, Rodrigues M, Parsad D
Indian J Dermatol Venereol Leprol 2023 Jan-Frebuary;89(1):41-46. doi: 10.25259/IJDVL_804_2021. PMID: 35593293
Vinay K, Bishnoi A, Parsad D, Saikia UN, Sendhil Kumaran M
Int J Dermatol 2017 Dec;56(12):1395-1399. Epub 2017 Oct 3 doi: 10.1111/ijd.13782. PMID: 28971471
Di Lernia V
Pediatr Dermatol 2007 May-Jun;24(3):205-10. doi: 10.1111/j.1525-1470.2007.00387.x. PMID: 17542865
Revuz J, Clerici T
J Am Acad Dermatol 1989 Apr;20(4):567-70. doi: 10.1016/s0190-9622(89)70064-5. PMID: 2715403

Diagnosis

Pye IM, Saw RPM, Saunderson RB
JAMA Dermatol 2023 Jan 1;159(1):96. doi: 10.1001/jamadermatol.2022.4550. PMID: 36449308
Wang RF, Ko D, Friedman BJ, Lim HW, Mohammad TF
J Am Acad Dermatol 2023 Feb;88(2):271-288. Epub 2022 Feb 11 doi: 10.1016/j.jaad.2022.01.051. PMID: 35151757
Nguyen K, Khachemoune A
Dermatol Online J 2019 May 15;25(5) PMID: 31220891
Kumarasinghe SPW, Pandya A, Chandran V, Rodrigues M, Dlova NC, Kang HY, Ramam M, Dayrit JF, Goh BK, Parsad D
Int J Dermatol 2019 Mar;58(3):263-272. Epub 2018 Sep 3 doi: 10.1111/ijd.14189. PMID: 30176055
Aurangabadkar SJ
Indian J Dermatol Venereol Leprol 2019 Jan-Feb;85(1):10-17. doi: 10.4103/ijdvl.IJDVL_1086_16. PMID: 30027914

Therapy

Shah S, Baskaran N, Vinay K, Bishnoi A, Parsad D, Kumaran MS
Int J Dermatol 2023 Dec;62(12):1447-1457. Epub 2023 Sep 28 doi: 10.1111/ijd.16859. PMID: 37767951
Taylor S, Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, Gonzalez N, Weiss J, Kang S, Desai SR
J Am Acad Dermatol 2023 Aug;89(2):316-323. Epub 2023 Mar 15 doi: 10.1016/j.jaad.2023.02.053. PMID: 36924935
Nguyen K, Khachemoune A
Dermatol Online J 2019 May 15;25(5) PMID: 31220891
Aurangabadkar SJ
Indian J Dermatol Venereol Leprol 2019 Jan-Feb;85(1):10-17. doi: 10.4103/ijdvl.IJDVL_1086_16. PMID: 30027914
Kauh YC, Zachian TF
Adv Exp Med Biol 1999;455:491-9. doi: 10.1007/978-1-4615-4857-7_72. PMID: 10599387

Prognosis

Shah S, Baskaran N, Vinay K, Bishnoi A, Parsad D, Kumaran MS
Int J Dermatol 2023 Dec;62(12):1447-1457. Epub 2023 Sep 28 doi: 10.1111/ijd.16859. PMID: 37767951
Polnikorn N, Tanghetti E
Dermatol Surg 2020 Dec;46(12):1651-1656. doi: 10.1097/DSS.0000000000002612. PMID: 32932271
North V, Gelman R, Tsang SH
Dev Ophthalmol 2014;53:44-52. Epub 2014 Apr 10 doi: 10.1159/000357293. PMID: 24732760Free PMC Article
Sathasivam S
Orphanet J Rare Dis 2008 Apr 17;3:9. doi: 10.1186/1750-1172-3-9. PMID: 18416855Free PMC Article
Revuz J, Clerici T
J Am Acad Dermatol 1989 Apr;20(4):567-70. doi: 10.1016/s0190-9622(89)70064-5. PMID: 2715403

Clinical prediction guides

Shah S, Baskaran N, Vinay K, Bishnoi A, Parsad D, Kumaran MS
Int J Dermatol 2023 Dec;62(12):1447-1457. Epub 2023 Sep 28 doi: 10.1111/ijd.16859. PMID: 37767951
Bishnoi A, Vinay K, Parsad D, Kumar S, Chatterjee D, Nahar Saikia U, Sendhil Kumaran M
Australas J Dermatol 2021 Aug;62(3):278-285. Epub 2021 Mar 4 doi: 10.1111/ajd.13567. PMID: 33660856
Dabas G, Vinay K, Parsad D, Kumar A, Kumaran MS
J Eur Acad Dermatol Venereol 2020 Feb;34(2):392-399. Epub 2019 Oct 31 doi: 10.1111/jdv.15987. PMID: 31566833
Vinay K, Bishnoi A, Parsad D, Saikia UN, Sendhil Kumaran M
Int J Dermatol 2017 Dec;56(12):1395-1399. Epub 2017 Oct 3 doi: 10.1111/ijd.13782. PMID: 28971471
Revuz J, Clerici T
J Am Acad Dermatol 1989 Apr;20(4):567-70. doi: 10.1016/s0190-9622(89)70064-5. PMID: 2715403

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...